CADTH | Evidence Driven
CADTH | Evidence Driven

Dapagliflozin for Chronic Kidney Disease Guidelines

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1608-000

Question

  1. What are the evidence-based guidelines regarding the use of dapagliflozin for the treatment of adults with chronic kidney disease?

Key Message

No relevant evidence-based guidelines were identified describing recommendations for best practice regarding the use of dapagliflozin for the treatment of adults with chronic kidney disease.

Files

Dapagliflozin for Chronic Kidney Disease Guidelines View PDF
Last Updated : February 9, 2022